UB Paderborn / Katalog / Suche / in CDI

A CHIP fellow's transition into practice: Building a complex coronary therapeutics program

Catheterization and cardiovascular interventions, 2020-11, Vol.96 (5), p.1058-1064

2020

Volltextzugriff (PDF)

Intracranial hemorrhage and Hyperperfusion syndrome following carotid artery stenting: Risk factors, prevention, and treatment

Journal of the American College of Cardiology, 2004-05, Vol.43 (9), p.1596-1605

2004

Volltextzugriff (PDF)

Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting

Catheterization and cardiovascular interventions, 2007-04, Vol.69 (5), p.690-696

2007

Volltextzugriff (PDF)

Relation of inflammation and benefit of statins after percutaneous coronary interventions

Circulation (New York, N.Y.), 2003-04, Vol.107 (13), p.1750-1756

2003

Volltextzugriff (PDF)

A CHIP FELLOW'S TRANSITION INTO PRACTICE: BUILDING A COMPLEX CORONARY THERAPEUTICS PROGRAM

Journal of the American College of Cardiology, 2020-03, Vol.75 (11), p.1509-1509

2020

Volltextzugriff (PDF)

Correlation of Point-of-Care ecarin clotting time versus activated clotting time with bivalirudin concentrations

The American journal of cardiology, 2003-05, Vol.91 (9), p.1110-1113

2003

Volltextzugriff (PDF)

Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration

Thrombosis research, 2004, Vol.113 (2), p.115-121

2004

Volltextzugriff (PDF)

Severe bilateral carotid stenosis: The impact of ipsilateral stenting on Doppler-defined contralateral stenosis

Journal of the American College of Cardiology, 2004-04, Vol.43 (8), p.1358-1362

2004

Volltextzugriff (PDF)

The challenge of valvular heart disease: when is it time to operate?

Cleveland Clinic journal of medicine, 2004-06, Vol.71 (6), p.463-465

2004

Volltextzugriff (PDF)

Ionic contrast substantially increases the activated clotting time in patients receiving abciximab and bivalirudin at the time of percutaneous coronary intervention

Journal of the American College of Cardiology, 2002-03, Vol.39, p.49-49

2002

Volltextzugriff (PDF)

Glycoprotein IIb/IIIa inhibitors: current indications and future prospects

The American journal of medicine, 2000-08, Vol.109 (3), p.252-254

2000

Volltextzugriff (PDF)

A quality framework for the role of invasive, non‐interventional cardiologists in the present‐day cardiac catheterization laboratory: A multidisciplinary SCAI/HFSA expert consensus statement

Catheterization and cardiovascular interventions, 2018-12, Vol.92 (7), p.1356-1364

2018

Volltextzugriff (PDF)

Direct Thrombin Inhibitors for Percutaneous Coronary Intervention in the Current Era of Platelet Glycoprotein IIb/IIIa Inhibition

Journal of interventional cardiology, 2002-04, Vol.15 (2), p.141-146

2002

Volltextzugriff (PDF)

Renal insufficiency in the setting of an acute coronary syndrome is associated with a marked increase in death and myocardial infarction at 30 days

Journal of the American College of Cardiology, 2003-03, Vol.41 (6), p.375-375

2003

Volltextzugriff (PDF)

Why diabetics are at risk in percutaneous coronary intervention and the appropriate management of diabetics in interventional cardiology

The Journal of invasive cardiology, 2002-12, Vol.14 Suppl E, p.2E-10E; quiz 11E

2002

Volltextzugriff (PDF)

GPIIb-IIIa receptor inhibitors: What the interventional radiologist needs to know

Cardiovascular and interventional radiology, 2001-11, Vol.24 (6), p.361-367

2001

Volltextzugriff (PDF)

Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting

Journal of the American College of Cardiology, 2004-05, Vol.43 (9), p.1596-1601

2004

Volltextzugriff (PDF)

Non-cardiac surgery in the heart failure patient

Heart (British Cardiac Society), 2001-05, Vol.85 (5), p.505-507

2001

Volltextzugriff (PDF)

Non-cardiac surgery in the heart failure patient

Heart (British Cardiac Society), 2001-05, Vol.85 (5), p.505-507

2001

Volltextzugriff (PDF)

Renal artery end-diastolic velocity and renal artery resistance index as predictors of outcome after renal stenting

The American journal of cardiology, 2001-11, Vol.88 (9), p.1064-1066

2001

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa antagonists are beneficial in patients with acute coronary syndromes who undergo in-hospital coronary artery bypass surgery

Journal of the American College of Cardiology, 2003-03, Vol.41 (6), p.351-352

2003

Volltextzugriff (PDF)

Severe bilateral carotid stenosis

Journal of the American College of Cardiology, 2004-04, Vol.43 (8), p.1358-1362

2004

Volltextzugriff (PDF)

Elevated baseline C-reactive protein is associated with increased risk of death and myocardial infarction at one year following percutaneous coronary intervention

Journal of the American College of Cardiology, 2003-03, Vol.41 (6), p.34-35

2003

Volltextzugriff (PDF)

Cerebral hyperperfusion and intracranial hemorrhage following internal carotid artery stenting

Journal of the American College of Cardiology, 2002-03, Vol.39, p.68-68

2002

Volltextzugriff (PDF)

Impact of the prediabetic state on long-term outcomes following percutaneous coronary intervention

Journal of the American College of Cardiology, 2003-03, Vol.41 (6), p.11-11

2003

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

A CHIP fellow's transition into practice: Building a complex coronary therapeutics program

Intracranial hemorrhage and Hyperperfusion syndrome following carotid artery stenting: Risk factors, prevention, and treatment

Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting

Relation of inflammation and benefit of statins after percutaneous coronary interventions

A CHIP FELLOW'S TRANSITION INTO PRACTICE: BUILDING A COMPLEX CORONARY THERAPEUTICS PROGRAM

Correlation of Point-of-Care ecarin clotting time versus activated clotting time with bivalirudin concentrations

Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration

Severe bilateral carotid stenosis: The impact of ipsilateral stenting on Doppler-defined contralateral stenosis

The challenge of valvular heart disease: when is it time to operate?

Ionic contrast substantially increases the activated clotting time in patients receiving abciximab and bivalirudin at the time of percutaneous coronary intervention

Glycoprotein IIb/IIIa inhibitors: current indications and future prospects

A quality framework for the role of invasive, non‐interventional cardiologists in the present‐day cardiac catheterization laboratory: A multidisciplinary SCAI/HFSA expert consensus statement

Direct Thrombin Inhibitors for Percutaneous Coronary Intervention in the Current Era of Platelet Glycoprotein IIb/IIIa Inhibition

Renal insufficiency in the setting of an acute coronary syndrome is associated with a marked increase in death and myocardial infarction at 30 days

Why diabetics are at risk in percutaneous coronary intervention and the appropriate management of diabetics in interventional cardiology

GPIIb-IIIa receptor inhibitors: What the interventional radiologist needs to know

Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting

Non-cardiac surgery in the heart failure patient

Non-cardiac surgery in the heart failure patient

Renal artery end-diastolic velocity and renal artery resistance index as predictors of outcome after renal stenting

Platelet glycoprotein IIb/IIIa antagonists are beneficial in patients with acute coronary syndromes who undergo in-hospital coronary artery bypass surgery

Severe bilateral carotid stenosis

Elevated baseline C-reactive protein is associated with increased risk of death and myocardial infarction at one year following percutaneous coronary intervention

Cerebral hyperperfusion and intracranial hemorrhage following internal carotid artery stenting

Impact of the prediabetic state on long-term outcomes following percutaneous coronary intervention

Suchergebnisse filtern